These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15680375

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
    Kirino Y, Sato Y, Kamimoto T, Kawazoe K, Minakuchi K, Nakahori Y.
    J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
    Wittmann S, Daniel C, Stief A, Vogelbacher R, Amann K, Hugo C.
    Transplantation; 2009 May 15; 87(9):1290-9. PubMed ID: 19424027
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
    Guo H, Gan L, Yu Z.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 10; 81(21):1327-9. PubMed ID: 16200729
    [Abstract] [Full Text] [Related]

  • 29. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B.
    J Am Soc Nephrol; 2007 Feb 10; 18(2):539-50. PubMed ID: 17202420
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Protective role of renal nerves in the development of diabetic nephropathy.
    Matsuoka H.
    Diabetes Res; 1993 Feb 10; 23(1):19-29. PubMed ID: 7924145
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats.
    Yamabe N, Yokozawa T, Oya T, Kim M.
    J Pharmacol Exp Ther; 2006 Oct 10; 319(1):228-36. PubMed ID: 16835369
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
    Wang J, Huang H, Liu P, Tang F, Qin J, Huang W, Chen F, Guo F, Liu W, Yang B.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):297-303. PubMed ID: 17074319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.